The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Losartan/Hydrochlorothiazide 50 mg/ 12.5 mg film-coated tablets

50 mg/12.5 milligram(s) Film-coated tablet

Rowex LtdPA0711/139/001

Main Information

Trade NameLosartan/Hydrochlorothiazide 50 mg/ 12.5 mg film-coated tablets
Active SubstancesLosartan potassium
Hydrochlorothiazide
Strength50 mg/12.5 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderRowex Ltd
Licence NumberPA0711/139/001

Group Information

ATC CodeC09DA Angiotensin II antagonists and diuretics
C09DA01 losartan and diuretics

Status

Authorised/WithdrawnAuthorised
Licence Issued20/03/2009
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0031-025-003
Interchangeable List DocumentPDF of Interchangeable List
« Back